What are the specific risks of using zolpidem for chronic insomnia in adults over 70?

✓ Accepted answer

Zolpidem, a non-benzodiazepine sedative-hypnotic, poses heightened safety risks for adults over 70, including increased fall risk, cognitive impairment, and complex behavioral reactions. Given the physiological changes in drug metabolism at this age, chronic use requires careful clinical oversight and a focus on non-pharmacological alternatives first.

• Heightened Risk of Falls: Adults over 70 on zolpidem face a significantly elevated risk of falls. This is due to the drug's residual sedation, which can cause morning grogginess and reduced reflexes. Research indicates that even a single dose can increase the risk of fractures, especially among those with pre-existing mobility issues.
• Complex Behaviors and Memory Gaps: In the US, the FDA and in the UK, the MHRA, have issued warnings regarding complex sleep behaviors such as sleepwalking, sleep-driving, and amnesia. For older adults, these side effects can be particularly dangerous and are more pronounced with zolpidem than with many other hypnotics.
• Metabolic Considerations: As hepatic function declines with age, zolpidem levels remain in the body longer, leading to excessive next-day sedation. Clinicians often recommend starting at the lowest effective dose, typically 5 mg for older adults, and titrating slowly.
• Alternatives: Before considering chronic pharmacological intervention, guidelines from bodies like the NICE in the UK emphasize Cognitive Behavioral Therapy for Insomnia (CBT-I) as the first-line treatment. This non-drug approach addresses the root causes of sleeplessness and carries no risk of morning confusion.

Always consult a geriatrician or a primary care provider to weigh these risks against benefits and explore safer, long-term sleep management strategies.

admin · 2026-10-13 20:16:20